$CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

2021 Q4 Form 10-Q Financial Statement

#000147793221008404 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $67.75K $10.00K $77.00K
YoY Change 287.14% -87.01% 33.91%
Cost Of Revenue $39.45K $4.000K $17.60K
YoY Change 393.13% -77.27% 120.0%
Gross Profit $28.30K $6.000K $59.40K
YoY Change 197.89% -89.9% 20.0%
Gross Profit Margin 41.77% 60.0% 77.14%
Selling, General & Admin $1.428M $757.2K $285.1K
YoY Change 352.2% 165.6% -10.24%
% of Gross Profit 5045.97% 12620.58% 479.97%
Research & Development $50.00K $59.18K $0.00
YoY Change
% of Gross Profit 176.68% 986.33% 0.0%
Depreciation & Amortization $23.02K $23.02K $16.77K
YoY Change 37.27% 37.27% 217.01%
% of Gross Profit 81.34% 383.67% 28.23%
Operating Expenses $1.501M $839.4K $301.9K
YoY Change 351.36% 178.08% -6.52%
Operating Profit -$1.473M -$833.4K -$242.5K
YoY Change 355.87% 243.73% -11.32%
Interest Expense -$2.403M $1.305M $289.2K
YoY Change -93.73% 351.32% -113.49%
% of Operating Profit
Other Income/Expense, Net -$1.010M $637.3K
YoY Change -258.5%
Pretax Income -$3.875M -$1.844M $394.9K
YoY Change -89.97% -566.91% -116.41%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$3.875M -$1.844M $394.9K
YoY Change -89.97% -566.91% -116.41%
Net Earnings / Revenue -5720.25% -18435.96% 512.79%
Basic Earnings Per Share -$0.75
Diluted Earnings Per Share -$1.113M -$0.75 $0.14
COMMON SHARES
Basic Shares Outstanding 2.452M shares 2.452M shares 685.0K shares
Diluted Shares Outstanding 2.452M shares 2.452M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.72M $2.378M $38.71K
YoY Change 10841.61% 6042.93% -75.54%
Cash & Equivalents $10.72M $2.378M $38.71K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $10.87K
Prepaid Expenses
Receivables $2.490K $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.74M $2.578M $38.71K
YoY Change 10855.01% 6559.6% -78.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.281K $3.280K
YoY Change
Total Long-Term Assets $531.0K $554.0K $386.5K
YoY Change -14.33% 43.32% 161.81%
TOTAL ASSETS
Total Short-Term Assets $10.74M $2.578M $38.71K
Total Long-Term Assets $531.0K $554.0K $386.5K
Total Assets $11.27M $3.132M $425.2K
YoY Change 1469.88% 636.5% 28.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $761.9K $454.5K $344.5K
YoY Change 117.12% 31.96% 6.38%
Accrued Expenses $24.39K $29.92K $155.6K
YoY Change -84.74% -80.77% 138.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.743M $908.5K
YoY Change -100.0% 201.97% 1.37%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.050M $3.495M $3.202M
YoY Change -97.41% 9.17% -17.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.050M $3.495M $3.202M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.050M $3.495M $3.202M
YoY Change -97.41% 9.17% -17.77%
SHAREHOLDERS EQUITY
Retained Earnings -$43.67M -$38.80M
YoY Change -29.44%
Common Stock $6.339K $2.458K
YoY Change 312.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.22M -$363.3K -$2.776M
YoY Change
Total Liabilities & Shareholders Equity $11.27M $3.132M $425.2K
YoY Change 1469.88% 636.5% 28.71%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$3.875M -$1.844M $394.9K
YoY Change -89.97% -566.91% -116.41%
Depreciation, Depletion And Amortization $23.02K $23.02K $16.77K
YoY Change 37.27% 37.27% 217.01%
Cash From Operating Activities -$1.161M -$390.8K -$174.0K
YoY Change -2138.14% 124.58% -51.43%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$200.0K
YoY Change
Cash From Investing Activities $200.0K -$200.0K
YoY Change -180.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.307M 2.810M 175.7K
YoY Change 3588.68% 1499.39% -43.76%
NET CHANGE
Cash From Operating Activities -1.161M -390.8K -174.0K
Cash From Investing Activities 200.0K -200.0K
Cash From Financing Activities 9.307M 2.810M 175.7K
Net Change In Cash 8.346M 2.219M 1.690K
YoY Change 13974.11% 131221.89% -103.68%
FREE CASH FLOW
Cash From Operating Activities -$1.161M -$390.8K -$174.0K
Capital Expenditures $0.00
Free Cash Flow -$1.161M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
17300 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
10800 USD
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2452348 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2377930 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98012 USD
CY2021Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
200000 USD
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
2577930 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
98012 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
3282 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
0 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
550700 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
619763 USD
CY2021Q3 us-gaap Assets
Assets
3131912 USD
CY2020Q4 us-gaap Assets
Assets
717775 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
454525 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
350899 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29920 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
159771 USD
CY2021Q3 us-gaap Management Fee Payable
ManagementFeePayable
250082 USD
CY2020Q4 us-gaap Management Fee Payable
ManagementFeePayable
468782 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
409649 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
788701 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
2743430 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
38741832 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3495257 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40520785 USD
CY2020Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2458250 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1537081 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2458242 shares
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16771 USD
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1537073 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2458 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1537 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38434192 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22082689 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38802995 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61890236 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-363345 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-39803010 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3131912 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
717775 USD
CY2021Q3 us-gaap Revenues
Revenues
10000 USD
CY2020Q3 us-gaap Revenues
Revenues
77000 USD
us-gaap Revenues
Revenues
20000 USD
us-gaap Revenues
Revenues
147000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
4000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
17600 USD
us-gaap Cost Of Revenue
CostOfRevenue
8500 USD
us-gaap Cost Of Revenue
CostOfRevenue
42596 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
6000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
59400 USD
us-gaap Gross Profit
GrossProfit
11500 USD
us-gaap Gross Profit
GrossProfit
104404 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59180 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59180 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
757235 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
285100 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1536479 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
846154 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23021 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
69063 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50021 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
839436 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
301871 USD
us-gaap Operating Expenses
OperatingExpenses
1664722 USD
us-gaap Operating Expenses
OperatingExpenses
896175 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-833436 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-242471 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1653222 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-791771 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
1305273 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
289210 USD
us-gaap Interest Expense
InterestExpense
1875687 USD
us-gaap Interest Expense
InterestExpense
910236 USD
CY2021Q3 celz Gain On Extinguishment Of Convertible Notes
GainOnExtinguishmentOfConvertibleNotes
489157 USD
CY2020Q3 celz Gain On Extinguishment Of Convertible Notes
GainOnExtinguishmentOfConvertibleNotes
0 USD
celz Gain On Extinguishment Of Convertible Notes
GainOnExtinguishmentOfConvertibleNotes
585601 USD
celz Gain On Extinguishment Of Convertible Notes
GainOnExtinguishmentOfConvertibleNotes
0 USD
CY2021Q3 celz Change In Fair Value Of Derivatives Liabilities
ChangeInFairValueOfDerivativesLiabilities
-194044 USD
CY2020Q3 celz Change In Fair Value Of Derivatives Liabilities
ChangeInFairValueOfDerivativesLiabilities
926532 USD
celz Change In Fair Value Of Derivatives Liabilities
ChangeInFairValueOfDerivativesLiabilities
26030549 USD
celz Change In Fair Value Of Derivatives Liabilities
ChangeInFairValueOfDerivativesLiabilities
3996775 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1010160 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
637322 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
24740463 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3086539 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1843596 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
394851 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23087241 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2294768 USD
CY2021Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
0 USD
CY2020Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
0 USD
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
0 USD
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1843596 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
394851 USD
us-gaap Net Income Loss
NetIncomeLoss
23087241 USD
us-gaap Net Income Loss
NetIncomeLoss
2294768 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.58
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
9.98
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
6.21
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2452076 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
684983 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2313005 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
369423 shares
CY2021Q3 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
2452076 shares
CY2020Q3 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
2725722 shares
us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
2363145 shares
us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
2138913 shares
us-gaap Net Income Loss
NetIncomeLoss
23087241 USD
us-gaap Net Income Loss
NetIncomeLoss
2294768 USD
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
595380 USD
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
68242 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
69063 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50021 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1755104 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
804898 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-26030549 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-3996775 USD
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
93821 USD
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-585601 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5600 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
103626 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
23666 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
26169 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
126838 USD
us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
-168700 USD
us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
131200 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1054446 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-491542 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
200000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-200000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3887750 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
celz Payments On Notes Payable
PaymentsOnNotesPayable
-105000 USD
celz Payments On Notes Payable
PaymentsOnNotesPayable
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
443239 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3282 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
celz Payments On Convertible Notes Payable
PaymentsOnConvertibleNotesPayable
0 USD
celz Payments On Convertible Notes Payable
PaymentsOnConvertibleNotesPayable
17000 USD
celz Proceeds From Convertible Notes Payable
ProceedsFromConvertibleNotesPayable
435040 USD
celz Proceeds From Convertible Notes Payable
ProceedsFromConvertibleNotesPayable
458600 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
462000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
226500 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
-220000 USD
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
705405 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3534364 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
441600 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2279918 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-49942 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98012 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88648 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2377930 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38706 USD
us-gaap Interest Paid Net
InterestPaidNet
9186 USD
us-gaap Interest Paid Net
InterestPaidNet
6000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
celz Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
27725 USD
celz Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
0 USD
celz Warrants Issued With Notes Payable And As A Service Fee
WarrantsIssuedWithNotesPayableAndAsAServiceFee
2097629 USD
celz Warrants Issued With Notes Payable And As A Service Fee
WarrantsIssuedWithNotesPayableAndAsAServiceFee
0 USD
celz Conversion Of Notes Payable Accrued Interest And Derivative Liabilities Into Common Stock
ConversionOfNotesPayableAccruedInterestAndDerivativeLiabilitiesIntoCommonStock
13747415 USD
celz Conversion Of Notes Payable Accrued Interest And Derivative Liabilities Into Common Stock
ConversionOfNotesPayableAccruedInterestAndDerivativeLiabilitiesIntoCommonStock
2772149 USD
celz Debt Conversion Converted Instrument Conversion Of Management Fees And Patent Liability
DebtConversionConvertedInstrumentConversionOfManagementFeesAndPatentLiability
50000 USD
celz Debt Conversion Converted Instrument Conversion Of Management Fees And Patent Liability
DebtConversionConvertedInstrumentConversionOfManagementFeesAndPatentLiability
160000 USD
celz Discounts On Convertible Notes Payable Due To Derivative Liabilities
DiscountsOnConvertibleNotesPayableDueToDerivativeLiabilities
134640 USD
celz Discounts On Convertible Notes Payable Due To Derivative Liabilities
DiscountsOnConvertibleNotesPayableDueToDerivativeLiabilities
0 USD
celz Exchange Of Preferred Stock For Notes Payable
ExchangeOfPreferredStockForNotesPayable
572275 USD
celz Exchange Of Preferred Stock For Notes Payable
ExchangeOfPreferredStockForNotesPayable
0 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-39803010 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-363345 USD
celz Proceeds From Sales Of Preferred Stock Amount
ProceedsFromSalesOfPreferredStockAmount
462000 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
50000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1383331 USD
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
12364084 USD
celz Dividends On Preferred Stock
DividendsOnPreferredStock
-27725 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
celz Warrants Issued With Notes Payable
WarrantsIssuedWithNotesPayable
2097629 USD
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-572275 USD
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
595380 USD
us-gaap Net Income Loss
NetIncomeLoss
23087241 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-714453 USD
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
153980 USD
CY2021Q3 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
138731 USD
CY2021Q3 celz Dividends On Preferred Stock
DividendsOnPreferredStock
-6973 USD
CY2021Q3 celz Warrants Issued With Notes Payable
WarrantsIssuedWithNotesPayable
2097629 USD
CY2021Q3 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-572275 USD
CY2021Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
383612 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1843596 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-363345 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-8071499 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
160000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1033418 USD
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
1738731 USD
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
68242 USD
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
0 USD
us-gaap Profit Loss
ProfitLoss
2294768 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-2776340 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-4204672 USD
CY2020Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
40000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
428162 USD
CY2020Q3 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
497077 USD
CY2020Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
68242 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
394851 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-2776340 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Use of Estimates</em></strong> – The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2452076 shares
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
394851 USD
CY2020Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
28228 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
423079 USD
CY2020Q3 us-gaap Diluted Earnings Per Share Pro Forma
DilutedEarningsPerShareProForma
0.16
us-gaap Diluted Earnings Per Share Pro Forma
DilutedEarningsPerShareProForma
9.77
us-gaap Diluted Earnings Per Share Pro Forma
DilutedEarningsPerShareProForma
1.12
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
684983 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
47784 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1579107 shares
CY2020Q3 celz Incremental Common Shares Attributable To Dilutive Effect Of Convertible Related Party Management Fee And Patent Liabilities
IncrementalCommonSharesAttributableToDilutiveEffectOfConvertibleRelatedPartyManagementFeeAndPatentLiabilities
413896 shares
us-gaap Interest Expense Other
InterestExpenseOther
804898 USD
celz Debt Conversion Shares Issued
DebtConversionSharesIssued
777865 shares
CY2021Q3 celz Initial Derivative Liabilities
InitialDerivativeLiabilities
1077757 USD
CY2021Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
0 USD
CY2021Q3 celz Percentages Of Preferred Shares Stated Value
PercentagesOfPreferredSharesStatedValue
1.20 pure

Files In Submission

Name View Source Status
0001477932-21-008404-index-headers.html Edgar Link pending
0001477932-21-008404-index.html Edgar Link pending
0001477932-21-008404.txt Edgar Link pending
0001477932-21-008404-xbrl.zip Edgar Link pending
celz-20210930.xsd Edgar Link pending
celz-20210930_cal.xml Edgar Link unprocessable
celz-20210930_def.xml Edgar Link unprocessable
celz-20210930_lab.xml Edgar Link unprocessable
celz-20210930_pre.xml Edgar Link unprocessable
celz_10q.htm Edgar Link pending
celz_10q_htm.xml Edgar Link completed
celz_ex311.htm Edgar Link pending
celz_ex312.htm Edgar Link pending
celz_ex321.htm Edgar Link pending
celz_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending